[go: up one dir, main page]

ES2171657T3 - Vector de dna recombinante para terapia genica. - Google Patents

Vector de dna recombinante para terapia genica.

Info

Publication number
ES2171657T3
ES2171657T3 ES96907399T ES96907399T ES2171657T3 ES 2171657 T3 ES2171657 T3 ES 2171657T3 ES 96907399 T ES96907399 T ES 96907399T ES 96907399 T ES96907399 T ES 96907399T ES 2171657 T3 ES2171657 T3 ES 2171657T3
Authority
ES
Spain
Prior art keywords
gene therapy
recombinant dna
dna vector
novel
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96907399T
Other languages
English (en)
Inventor
Walter H Gunzburg
Brian Salmons
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Austrian Nordic Biotherapeutics AG
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Original Assignee
Austrian Nordic Biotherapeutics AG
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Austrian Nordic Biotherapeutics AG, Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH filed Critical Austrian Nordic Biotherapeutics AG
Application granted granted Critical
Publication of ES2171657T3 publication Critical patent/ES2171657T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVOS VECTORES RECOMBINANTES UTILES PARA TERAPIA GENICA DE INFECCIONES VIRALES Y DE ENFERMEDADES ASOCIADAS CON LAS CELULAS T Y B. LA PRESENTE INVENCION SE REFIERE, ADICIONALMENTE, A NUEVOS USOS DE LOS DOS PRODUCTOS DEL MARCO ABIERTO DE LECTURA DEL VIRUS DE TUMOR MAMARIO EN RATONES.
ES96907399T 1995-03-09 1996-03-08 Vector de dna recombinante para terapia genica. Expired - Lifetime ES2171657T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK24495 1995-03-09

Publications (1)

Publication Number Publication Date
ES2171657T3 true ES2171657T3 (es) 2002-09-16

Family

ID=8091367

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96907399T Expired - Lifetime ES2171657T3 (es) 1995-03-09 1996-03-08 Vector de dna recombinante para terapia genica.

Country Status (9)

Country Link
US (1) US6730511B1 (es)
EP (2) EP0817859B1 (es)
JP (1) JPH11508441A (es)
AT (1) ATE212061T1 (es)
AU (1) AU5104096A (es)
DE (1) DE69618579T2 (es)
DK (1) DK0817859T3 (es)
ES (1) ES2171657T3 (es)
WO (1) WO1996028564A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2199585C2 (ru) * 1994-09-02 2003-02-27 ГСФ-Форшунгсцентрум фюр Умвельт унд Гезундхайт ГмбХ Ретровирусная векторная конструкция, подвергающаяся промоторной конверсии, способ введения гомологичных или гетерологичных нуклеотидных последовательностей в человеческие или животные клетки in vitro и/или in vivo, рекомбинантная ретровирусная частица, фармацевтическая композиция для генной терапии
ES2198479T3 (es) 1995-03-09 2004-02-01 Gsf-Forschungszentrum Fur Umwelt Und Gesundheit Gmbh Vectores que llevan genes terapeuticos codificantes de peptidos antimicrobianos para terapia genica.
DE19910650A1 (de) * 1999-03-10 2000-09-21 Gsf Forschungszentrum Umwelt Auf HERV-LTR-Sequenzen basierende retrovirale Expressionsvektoren
DE102009024862A1 (de) 2009-06-09 2010-12-16 Uwe Michael Schlitt Dosiervorrichtung für flüssige Medien

Also Published As

Publication number Publication date
JPH11508441A (ja) 1999-07-27
AU5104096A (en) 1996-10-02
EP1162273A1 (en) 2001-12-12
DK0817859T3 (da) 2002-04-29
EP0817859A1 (en) 1998-01-14
DE69618579T2 (de) 2002-10-02
EP0817859B1 (en) 2002-01-16
ATE212061T1 (de) 2002-02-15
DE69618579D1 (de) 2002-02-21
WO1996028564A1 (en) 1996-09-19
US6730511B1 (en) 2004-05-04

Similar Documents

Publication Publication Date Title
ATE369428T1 (de) Behandlung von gebärmutterhalskrebs
DE69820450D1 (de) Chimäre vektoren, die die verpackungsregion eines phagengenoms und einen teil des genoms eines eukaryontischen virus enthalten
ES2172502T3 (es) Receptores tipo ii de interleucina 1.
DK0863202T3 (da) Rekombinant Sendai-virus
ATE231551T1 (de) Huntingtin-dna, protein und verwendung
FI951138A7 (fi) Puuttellisia adenovirusvektoreita ja niiden käyttö geeniterapiassa
CY1117384T1 (el) Μεθοδοι για την παραγωγη παρασκευασματων ανασυνδυασμενων φορεων aav υψηλου τιτλου απαλλαγμενων απο βοηθητικους ιους
ATE315087T1 (de) Neuartige auf p53 ansprechende gene
CY1106513T1 (el) Λεντινοϊικο τριπλο dna και οχηματα και ανασυνδυασμενα κυτταρα που περιεχουν λεντινοϊικο τριπλο dna
KR950032279A (ko) 인체의 프로그램된 세포 사멸과 관련 있는 펩티드 및 이를 암호하는 디엔에이(dna)
ATE260980T1 (de) Die erzielung hoher titer des rekombinanten aav- vektors
EP0866721A4 (en) TARGET ADENOVIRAL VECTORS
EP0910406A4 (en) RECOMBINANT RABBIT HERPESVIRUS
ATE141946T1 (de) Hiv-2-virusvarianten
HUP9801608A2 (hu) A 11. típusú humán papillomavírusból származó L1-fehérjét kódoló szintetikus HPV6/11-L1-hibrid-DNS
DK0817851T3 (da) DNA, der koder for humant papillomvirus type 18
ES2171657T3 (es) Vector de dna recombinante para terapia genica.
WO1994013812A3 (en) Novel entomopoxvirus genes, proteins and methods of use thereof
PT828844E (pt) Promotores para a expressao de genes
ATE234362T1 (de) Konditionell-replizierende virale vektoren und ihre verwendung.
ATE302214T1 (de) Enamel-matrix bezogene polypeptide
BR9909044A (pt) Vetor de tranferência de ácidos nucleicos, composição, utilização de um vetor de tranferência de ácidos nucleicos, processos de transfecção de ácidos nucleicos nas células, e de tratamento de doenças, e, célula recombinante
ATE435915T1 (de) Spezifische nukleinsäuren und polypeptide aus krankheitserregenden stämmen von neisseria
WO1992014818A3 (en) Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences
CA2237059A1 (en) Targeted adenovirus vectors

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 817859

Country of ref document: ES